DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rallied 1.28% to $458.99 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,420.10 and Dow Jones Industrial Average falling 0.98% to 51,492.55.
This was the stock's third consecutive day of gains.
Vertex Pharmaceuticals Inc. closed 9.63% short of its 52-week high of $507.92, which the company reached on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ fell 0.56% to $221.23, Krystal Biotech Inc. (KRYS) rose 5.66% to $341.66, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 3.08% to $7.36.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 17, 2026 16:38 ET (20:38 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments